SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-08 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change
26-07-31	€0.0599	+1.01%
26-07-30	€0.0593	-4.20%
26-07-29	€0.0619	-3.58%
26-07-28	€0.0642	-2.73%
26-07-27	€0.0660	+0.92%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Market Closed - Deutsche Boerse AG Other stock markets 03:07:53 2026-07-31 EDT			5-day change	1st Jan Change
0.0599 ^EUR	+1.01%		-8.41%	-27.92%

07-28	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
07-27	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI

Market Cap	7.81M 8.99M 7.27M 6.68M 12.61M 858M 12.8M 85.71M 33.64M 427M 33.75M 33.01M 1.43B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	7.55M 8.68M 7.02M 6.45M 12.18M 829M 12.37M 82.79M 32.49M 413M 32.6M 31.89M 1.38B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.68%	Yield 2024 *	-	Yield 2025	-

07-28	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
07-27	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
07-27	SpineGuard Secures a New Patent in the United States
07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026
05-27	SpineGuard Secures Three Patent Applications in US	MT
05-26	SpineGuard granted three new patents in the United States
05-26	Spineguard Obtains Three New Patents for Full Protection in the United States of Its Innovative Solutions Integrating Dsg Technology	CI
04-28	SpineGuard Officially Launches Newly Cleared Curved and XS PediGuard Models, in Nanjing	CI
04-14	SpineGuard Transfers US Unit's Assets, Executes Distribution Deal with Omnia Medical	MT
04-13	SpineGuard and Omnia Medical Complete Us Asset Transfer and Enter Exclusive Distribution Agreement for Pediguard Devices	CI
04-13	Omnia Medical, LLC completed the acquisition of Spineguard, Inc. from SpineGuard SA.	CI
04-08	SpineGuard SA Auditor Raises 'Going Concern' Doubt	CI

07-27	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
07-08	SpineGuard Announces its H1 2026 Revenue	BU
05-26	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU
04-28	SpineGuard : Official launch of three New PediGuard® Models during the Annual Scoliosis Meeting in China	PU
04-28	SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China	BU

SpineGuard Stock Deutsche Boerse AG

Stocks

6W5

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news : SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Course Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

07-27	SpineGuard obtient un nouveau brevet aux Etats-Unis
07-27	SpineGuard et Omnia Medical obtiennent un nouveau brevet américain pour leur application innovante de la technologie DSG à la fusion de l'articulation sacro-iliaque
07-23	SpineGuard : Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF
07-08	SpineGuard en mesure de financer son activité jusqu'au deuxième trimestre 2027
07-08	SpineGuard annonce son chiffre d’affaires du premier semestre 2026

1 day	+1.01%
1 week	-8.41%
1 month	-0.66%
3 months	-17.83%
6 months	-26.05%
Current year	-27.92%

1 week	0.06	0.07
1 month	0.06	0.07
Current year	0.06	0.14
1 year	0.06	0.25
3 years	0.06	0.49
5 years	0.06	1.72
10 years	0.06	2.91

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	2020-02-14
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	2008-12-31
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	2019-08-31

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	2009-01-15
Maurice Bourlion BRD	Director/Board Member	-	2009-07-01
Pierre Jérôme CHM	Chairman	-	2018-02-28

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	+1.01%	-8.41%	-	-	8.99M
PENUMBRA, INC.	+0.43%	+0.77%	+32.17%	+7.66%	12.65B
GETINGE AB	+0.55%	+3.08%	+25.28%	+19.48%	6.78B
ASAHI INTECC CO., LTD.	-0.80%	+6.33%	+50.71%	+21.80%	5.98B
MINIMED GROUP, INC.	-0.52%	+7.25%	-	-	5.07B
APT MEDICAL INC.	+3.47%	+9.59%	-18.67%	+44.43%	4.75B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+0.32%	+5.56%	-19.89%	-16.85%	4.15B
IMPLANTICA AG	+0.32%	+5.10%	-25.54%	+205.94%	1.84B
NOVOCURE LIMITED	-2.56%	-15.92%	+31.10%	-54.55%	1.73B
NAKANISHI INC.	+1.27%	-0.82%	+53.75%	-8.45%	1.58B
Average	+0.35%	+2.09%	+16.11%	+27.43%	4.95B
Weighted average by Cap.	+0.40%	+3.26%	+20.34%	+19.54%

	2024	2025
Net sales	4.65M 5.35M 4.33M 3.97M 7.5M 510M 7.62M 51M 20.01M 254M 20.08M 19.64M 852M	3.76M 4.32M 3.5M 3.21M 6.06M 413M 6.16M 41.22M 16.18M 205M 16.23M 15.88M 689M
Net income	-3.08M -3.55M -2.87M -2.63M -4.97M -338M -5.05M -33.81M -13.27M -168M -13.31M -13.02M -565M	-2.07M -2.38M -1.92M -1.77M -3.34M -227M -3.39M -22.68M -8.9M -113M -8.93M -8.74M -379M
Net Debt	1.82M 2.09M 1.69M 1.55M 2.93M 200M 2.98M 19.95M 7.83M 99.43M 7.86M 7.68M 333M	-265K -305K -247K -227K -428K -29.14M -435K -2.91M -1.14M -14.51M -1.15M -1.12M -48.65M